India to Brazil: Ibrutinib Export Trade Route

The India to Brazil Ibrutinib corridor is one of India's established pharmaceutical export routes, with 158 shipments documented worth a combined $536.6K USD. The route is dominated by NIVIRA EXPORTS, which alone accounts for roughly 44% of all export value, reflecting the consolidated nature of India's ibrutinib manufacturing sector.

Across 13 active suppliers, the average shipment value stands at $3.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with ibrutinib's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 20.4%, placing it at rank #16 among India's top ibrutinib export destinations globally.

On the import side, key buyers of Indian ibrutinib in Brazil include TO THE,, VALTER LUIZ CACHELLI, TO THE and 59 others. TO THE, is the single largest importer with 38 shipments valued at $139.8K USD.

India's ibrutinib exports to Brazil are driven primarily by a handful of large-scale manufacturers. NIVIRA EXPORTS with 54 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 13 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — NIVIRA EXPORTS, VAMA LIFECARE PRIVATE LIMITED, RBN MEDITECH PRIVATE LIMITED — together account for 90% of total trade value on this route. The average shipment value of $3.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless pharmaceutical medicine going for human consumption: ibrutinib 140 mg capsules (imbruvica) [12 pack x 90's] and harmless pharmaceutical medicine going for human consumption: ibrutinib 140 mg capsules (imbruvica) [10 pack x 90's], suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE, is the largest importer with 38 shipments worth $139.8K USD — representing 26% of all ibrutinib imports from India on this route. A total of 62 buyers are active on this corridor.